See the DrugPatentWatch profile for cosentyx

While I am an AI language model and cannot guarantee the absolute accuracy of the information, I can provide a response based on the available data. According to DrugPatentWatch.com, Cosentyx (secukinumab) is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].

Lowering the dosage of Cosentyx might lead to reduced efficacy in treating the targeted conditions. However, specific side effects resulting from a lower dosage may vary among individuals. It is essential to consult a healthcare professional before making any changes to a medication regimen.

It is important to note that the most common side effects of Cosentyx, as reported by the FDA, include cold symptoms, diarrhea, and upper respiratory infections [2]. These side effects are generally associated with the standard dosage and may or may not be experienced by patients who lower their dosage.

In summary, lowering the Cosentyx dosage might cause reduced efficacy in treating the targeted conditions and potentially increase the risk of experiencing the common side effects associated with the medication. Consult a healthcare professional for personalized advice.

Sources:
[1] DrugPatentWatch.com - Cosentyx (secukinumab)
[2] FDA - Cosentyx (secukinumab) medication guide